Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study
By demonstrating the content validity of actigraphy measures of physical functioning, this qualitative study begins to address the evidence gaps identified by the regulatory requirements for using actigraphy endpoints in future PAH and CTEPH clinical trials.
Authors
- Alexander Rothman (ORCID: https://orcid.org/0000-0002-7847-4500)
- David Gerard Kiely (ORCID: https://orcid.org/0000-0003-0184-6502)
- Amélie Beaudet (ORCID: https://orcid.org/0000-0003-0535-672X)
- Nadia Pillai (ORCID: https://orcid.org/0000-0003-2076-9100)
- Frances Varian (ORCID: https://orcid.org/0000-0002-4644-8391)
- Stacy N. Davis (ORCID: https://orcid.org/0000-0003-4201-0891)
- Kimberly Kelly
- Rachael Kendrew
- Salma Ajraoui
Institutions
- Royal Hallamshire Hospital (GB)
- IQVIA (United Kingdom) (GB)
- IQVIA (United States) (US)
- Janssen (United States) (US)
- IQ Solutions (US)
- University of Sheffield (GB)
- Actelion (Switzerland) (CH)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12890-024-03442-7
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Actelion Pharmaceuticals